Zovoilis Lab

03/19/2025

03/07/2025

A groundbreaking research initiative, PrairieGen, is set to redefine how chronic and genetic diseases – such as cancer, inflammatory bowel disease, multiple sclerosis, metabolic disorders, and pediatric disorders – are detected and treated.

Genome Prairie has announced a $7.2 million investment through Genome Canada and partners to improve healthcare delivery and patient outcomes in the Prairie provinces. Over the next four years, researchers will conduct the largest genomics study ever undertaken in the region, analyzing the DNA of more than 3,000 individuals from Manitoba and Saskatchewan. This ambitious project will place the Prairies at the forefront of cutting-edge medical research and innovation, uncovering life-changing insights into genetic and molecular drivers of disease.

Read more: https://brnw.ch/21wR9Bl

11/08/2024

https://news.umanitoba.ca/um-researchers-using-ai-to-improve-cancer-research-and-early-detection-of-genetic-diseases/

UM researchers recently developed a new genomics method with the potential to reveal the genetic mechanisms behind human health and disease. The recent publication in the journal Genome Biology offers